MeSH term
Frequency | Condition_Probility | Animals | 63 | 0.0 |
Antineoplastic Agents/*pharmacology | 2 | 0.0 |
Brain Neoplasms/*drug therapy/pathology | 2 | 25.0 |
Cell Cycle/drug effects | 2 | 0.0 |
Cell Survival/drug effects | 2 | 0.0 |
Hemolysis | 8 | 2.0 |
Humans | 188 | 0.0 |
Male | 75 | 0.0 |
Rats | 32 | 0.0 |
Research Support, Non-U.S. Gov't | 90 | 0.0 |
Structure-Activity Relationship | 5 | 0.0 |
Tumor Cells, Cultured/*drug effects/pathology | 2 | 12.0 |
Case-Control Studies | 2 | 0.0 |
Enzyme-Linked Immunosorbent Assay/*methods | 2 | 1.0 |
Research Support, U.S. Gov't, P.H.S. | 59 | 0.0 |
*Cell Transformation, Neoplastic | 2 | 0.0 |
Tumor Cells, Cultured | 15 | 0.0 |
Disease Models, Animal | 3 | 0.0 |
English Abstract | 8 | 0.0 |
Female | 63 | 0.0 |
Neoplasm Transplantation | 5 | 0.0 |
Rats, Sprague-Dawley | 3 | 0.0 |
Transfection | 4 | 0.0 |
Adult | 45 | 0.0 |
Motor Cortex/*physiology | 2 | 10.0 |
Movement/*physiology | 2 | 5.0 |
Psychomotor Performance/physiology | 2 | 4.0 |
Binding Sites | 6 | 0.0 |
In Vitro | 11 | 0.0 |
Brain/metabolism | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 9 | 0.0 |
Transplantation, Heterologous | 2 | 0.0 |
Amino Acid Sequence | 16 | 0.0 |
Base Sequence | 18 | 0.0 |
Molecular Sequence Data | 21 | 0.0 |
Phylogeny | 2 | 0.0 |
RNA, Messenger/metabolism | 7 | 0.0 |
Cations | 2 | 2.0 |
Complement Hemolytic Activity Assay | 5 | 10.0 |
Complement Membrane Attack Complex/metabolism | 4 | 11.0 |
Complement Pathway, Alternative | 5 | 4.0 |
Microspheres | 3 | 1.0 |
Bacterial Outer Membrane Proteins/immunology | 2 | 10.0 |
Complement Pathway, Classical | 3 | 2.0 |
Adolescent | 15 | 0.0 |
Cryoglobulins/analysis | 2 | 18.0 |
Pedigree | 20 | 0.0 |
Blotting, Northern | 4 | 0.0 |
Cells, Cultured | 9 | 0.0 |
Complement/*genetics | 5 | 8.0 |
Complement 6/genetics | 4 | 44.0 |
Complement 8/genetics | 2 | 100.0 |
Complement 9/genetics | 2 | 33.0 |
Reverse Transcriptase Polymerase Chain Reaction | 5 | 0.0 |
Carcinoma, Hepatocellular/*pathology | 2 | 4.0 |
DNA Primers/chemistry | 2 | 0.0 |
Injections, Subcutaneous | 2 | 0.0 |
Mice | 18 | 0.0 |
Mice, Nude | 4 | 0.0 |
Polymerase Chain Reaction | 9 | 0.0 |
Polymorphism, Single-Stranded Conformational | 2 | 0.0 |
Rats, Inbred F344 | 4 | 1.0 |
Biomechanics | 2 | 1.0 |
Reproducibility of Results | 3 | 0.0 |
Spinal Diseases/*surgery | 2 | 100.0 |
Aged | 22 | 0.0 |
Middle Aged | 33 | 0.0 |
Binding, Competitive | 3 | 0.0 |
Kinetics | 5 | 0.0 |
Protein Conformation | 3 | 0.0 |
Recombinant Proteins/chemistry/metabolism | 2 | 0.0 |
Brain Neoplasms/*pathology | 3 | 4.0 |
DNA Primers | 3 | 0.0 |
Glioma/*pathology | 3 | 5.0 |
*Promoter Regions (Genetics) | 3 | 0.0 |
Comparative Study | 20 | 0.0 |
Linear Models | 2 | 0.0 |
Species Specificity | 6 | 0.0 |
Child | 18 | 0.0 |
Combined Modality Therapy | 2 | 0.0 |
Cell Line | 12 | 0.0 |
Insulin-Like Growth Factor I/*genetics | 2 | 8.0 |
Protein Binding | 2 | 0.0 |
African Continental Ancestry Group/*genetics | 2 | 0.0 |
Complement 6/*deficiency/*genetics | 4 | 80.0 |
Gene Deletion | 3 | 0.0 |
Neisseria meningitidis/immunology | 2 | 33.0 |
Point Mutation | 2 | 0.0 |
Follow-Up Studies | 2 | 0.0 |
Quality of Life | 2 | 1.0 |
Ecuador | 2 | 18.0 |
*Gene Frequency | 3 | 0.0 |
Phenotype | 10 | 0.0 |
Immune Sera | 5 | 1.0 |
Mutagenesis | 2 | 0.0 |
Epithelium/metabolism | 2 | 0.0 |
Immunoglobulin M/analysis | 3 | 1.0 |
Aged, 80 and over | 6 | 0.0 |
Alzheimer Disease/*metabolism | 3 | 1.0 |
Immunohistochemistry | 8 | 0.0 |
Reference Values | 3 | 0.0 |
Cell Survival | 2 | 0.0 |
Enzyme-Linked Immunosorbent Assay | 6 | 0.0 |
Time Factors | 4 | 0.0 |
Alleles | 10 | 0.0 |
Genotype | 4 | 0.0 |
Haplotypes | 5 | 0.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Sex Factors | 2 | 0.0 |
Antibodies, Monoclonal/immunology | 3 | 0.0 |
Antigens, Viral/*immunology | 2 | 2.0 |
Immunoblotting | 6 | 0.0 |
Precipitin Tests | 2 | 0.0 |
Exons | 7 | 0.0 |
Genetic Markers | 6 | 0.0 |
*Mutation | 2 | 0.0 |
Blotting, Southern | 2 | 0.0 |
Complement 6/*genetics | 4 | 28.0 |
Blotting, Western | 5 | 0.0 |
Gene Expression | 2 | 0.0 |
Antibodies/immunology | 2 | 0.0 |
Complement Activation/physiology | 2 | 10.0 |
Neurons/*metabolism | 3 | 1.0 |
Gliosarcoma/*pathology | 2 | 66.0 |
Hamsters | 2 | 0.0 |
African Continental Ancestry Group/genetics | 2 | 0.0 |
Motor Neurons/*pathology | 2 | 10.0 |
Complement Pathway, Classical/*physiology | 2 | 18.0 |
Tissue Distribution | 2 | 0.0 |
Complement/*metabolism | 6 | 3.0 |
Chromatography, High Pressure Liquid | 3 | 0.0 |
Trypsin | 3 | 1.0 |
Hela Cells | 2 | 0.0 |
Chromatography, Gel | 2 | 0.0 |
Complement 6/*deficiency/*genetics/immunology | 2 | 100.0 |
Complement Activation/immunology | 2 | 6.0 |
DNA/analysis | 3 | 0.0 |
Immunization | 2 | 0.0 |
Rats, Mutant Strains/*genetics/immunology | 2 | 100.0 |
Calcium/metabolism | 2 | 0.0 |
Complement Pathway, Alternative/*physiology | 2 | 20.0 |
Chromosome Mapping | 3 | 0.0 |
Chromosomes, Artificial, Yeast | 2 | 0.0 |
DNA Probes | 2 | 0.0 |
Gene Library | 2 | 0.0 |
Introns | 5 | 0.0 |
Linkage (Genetics) | 2 | 0.0 |
Macromolecular Substances | 3 | 0.0 |
Restriction Mapping | 3 | 0.0 |
Polymorphism, Genetic | 6 | 0.0 |
Prospective Studies | 4 | 0.0 |
Complement/*analysis | 11 | 6.0 |
Glycoproteins/analysis | 2 | 3.0 |
Microscopy, Electron | 3 | 0.0 |
*Molecular Chaperones | 2 | 1.0 |
Rabbits | 12 | 0.0 |
Asian Continental Ancestry Group | 2 | 0.0 |
Mutation | 4 | 0.0 |
Flow Cytometry | 2 | 0.0 |
Postoperative Period | 2 | 0.0 |
Complement Inactivators/pharmacology | 2 | 16.0 |
Dogs | 2 | 0.0 |
Papio | 2 | 1.0 |
Gene Frequency | 7 | 0.0 |
Cloning, Molecular | 4 | 0.0 |
Complement 7/*genetics | 2 | 13.0 |
Genomic Library | 2 | 0.0 |
Complement/*biosynthesis | 5 | 13.0 |
Complement 3/biosynthesis | 2 | 7.0 |
Complement 6/biosynthesis | 3 | 75.0 |
Complement 7/biosynthesis | 2 | 100.0 |
Complement Membrane Attack Complex/biosynthesis | 2 | 28.0 |
Electrophoresis, Polyacrylamide Gel | 9 | 0.0 |
Antibodies, Monoclonal | 3 | 0.0 |
Immunologic Techniques | 2 | 0.0 |
Complement 7/deficiency/*genetics | 2 | 50.0 |
Microscopy, Fluorescence | 3 | 0.0 |
Blood Bactericidal Activity | 2 | 2.0 |
Complement Membrane Attack Complex | 7 | 8.0 |
Epitopes | 3 | 0.0 |
*Complement Activation | 4 | 1.0 |
Immunoenzyme Techniques | 2 | 0.0 |
Blood Proteins/*genetics | 3 | 1.0 |
*Polymorphism, Genetic | 3 | 0.0 |
*Variation (Genetics) | 2 | 0.0 |
Complement/physiology | 2 | 4.0 |
Complement 6/*deficiency/genetics | 3 | 75.0 |
Immunity, Cellular | 2 | 0.0 |
Rats, Inbred Lew | 2 | 0.0 |
Cell Division/*drug effects | 2 | 0.0 |
Epithelial Cells | 2 | 0.0 |
Cell Membrane/metabolism | 2 | 0.0 |
*Complement Pathway, Alternative | 3 | 2.0 |
Fluorescent Antibody Technique | 9 | 0.0 |
Arthritis, Rheumatoid/*immunology | 2 | 0.0 |
Complement 6/deficiency/*genetics | 2 | 66.0 |
Deoxyribonuclease HpaII | 2 | 2.0 |
*Haplotypes | 2 | 0.0 |
*Polymorphism, Restriction Fragment Length | 2 | 0.0 |
Polymorphism, Genetic/*genetics | 2 | 0.0 |
Mice, Inbred BALB C | 2 | 0.0 |
Cattle | 2 | 0.0 |
Cross Reactions | 3 | 0.0 |
Chromatography, Ion Exchange | 2 | 0.0 |
Heat | 2 | 0.0 |
Properdin/metabolism | 2 | 13.0 |
Clone Cells/immunology | 2 | 1.0 |
Complement 6/*deficiency | 7 | 100.0 |
*Nerve Degeneration | 2 | 8.0 |
Sequence Homology, Nucleic Acid | 2 | 0.0 |
Fatty Acids/*analysis | 2 | 11.0 |
Complement 7/analysis | 4 | 36.0 |
Isoelectric Focusing | 4 | 0.0 |
Molecular Weight | 3 | 0.0 |
Italy | 2 | 0.0 |
Blood Proteins/*metabolism | 2 | 1.0 |
Antigens | 2 | 2.0 |
Immunoglobulin G | 4 | 3.0 |
Rats, Inbred Strains | 4 | 0.0 |
Reaction Time/physiology | 2 | 2.0 |
Complement Activation/*drug effects | 4 | 4.0 |
Complement 5/biosynthesis | 2 | 20.0 |
Complement 8/biosynthesis | 2 | 66.0 |
Complement 9/biosynthesis | 2 | 100.0 |
Cycloheximide/pharmacology | 2 | 0.0 |
Sepharose | 3 | 5.0 |
Complement Activation | 6 | 2.0 |
Glomerulonephritis, IGA/immunology | 2 | 66.0 |
Glomerulonephritis, Membranoproliferative/immunology | 2 | 33.0 |
Glomerulonephritis, Membranous/immunology | 2 | 100.0 |
Cell Line, Tumor | 2 | 0.0 |
Child, Preschool | 5 | 0.0 |
Infant | 3 | 0.0 |
Complement 6/metabolism | 3 | 30.0 |
Complement 5/*metabolism | 2 | 8.0 |
Complement 5/analysis | 5 | 11.0 |
Complement 5a | 2 | 6.0 |
Glomerulonephritis/*immunology | 3 | 7.0 |
HLA Antigens/*genetics | 2 | 0.0 |
Japan | 4 | 0.0 |
Complement/*deficiency | 5 | 10.0 |
*Linkage (Genetics) | 3 | 0.0 |
Antigen-Antibody Reactions | 3 | 0.0 |
Complement/*analysis/immunology | 2 | 22.0 |
Binding Sites, Antibody | 2 | 0.0 |
Myelin Sheath/*immunology | 2 | 15.0 |
Complement 6/*biosynthesis | 2 | 100.0 |
Complement 3b/metabolism | 2 | 1.0 |
Cell Membrane/immunology | 2 | 0.0 |
Immunoglobulin A/analysis | 2 | 1.0 |
Immunoglobulin G/analysis | 3 | 0.0 |
Complement/*biosynthesis/isolation & purification | 2 | 66.0 |
Complement 3/metabolism | 5 | 1.0 |
Complement 3 Convertase | 2 | 22.0 |
Guinea Pigs | 3 | 0.0 |
Sheep | 5 | 0.0 |
Antibodies, Monoclonal/*immunology | 2 | 0.0 |
Antibody Specificity | 4 | 0.0 |
Fibroblasts/immunology | 2 | 2.0 |
Complement/analysis | 3 | 2.0 |
Hemolytic Plaque Technique | 2 | 3.0 |
Immunodiffusion | 7 | 2.0 |
Electrophoresis, Agar Gel | 2 | 0.0 |
Pregnancy | 3 | 0.0 |
Basement Membrane/immunology | 4 | 7.0 |
Complement 5/metabolism | 4 | 9.0 |
Complement 7/metabolism | 2 | 20.0 |
Complement 3/immunology | 2 | 2.0 |
Immunoelectrophoresis, Two-Dimensional | 2 | 1.0 |
Culture Techniques | 2 | 0.0 |
Complement 3/analysis | 4 | 1.0 |
Complement 3d | 2 | 2.0 |
Complement 4/analysis | 4 | 1.0 |
Complement 6/analysis | 6 | 46.0 |
Complement 9/analysis | 3 | 11.0 |
Placenta/*immunology | 2 | 9.0 |
Immune Sera/immunology | 2 | 1.0 |
Antigen-Antibody Complex/*analysis | 2 | 1.0 |
Lupus Erythematosus, Systemic/immunology | 2 | 1.0 |
Complement 2/analysis | 2 | 6.0 |
Immunoelectrophoresis | 5 | 2.0 |
Complement 6/*deficiency/genetics/immunology | 2 | 100.0 |
Complement 1/analysis | 4 | 8.0 |
Cornea/*immunology | 2 | 16.0 |
*Hemolysis | 5 | 5.0 |
*Complement | 4 | 6.0 |
Transplantation, Homologous | 2 | 0.0 |
Chemotaxis | 3 | 1.0 |
Erythrocytes/immunology | 2 | 0.0 |
Antigen-Antibody Complex | 2 | 1.0 |
*HLA Antigens | 2 | 0.0 |
*Histocompatibility Antigens | 2 | 2.0 |
Immune Adherence Reaction | 3 | 6.0 |
Blood Proteins/analysis | 2 | 1.0 |
Histamine Release | 2 | 3.0 |
Macaca | 2 | 2.0 |
*Complement/analysis | 2 | 25.0 |
Goats/immunology | 3 | 14.0 |
Hemagglutination Tests | 2 | 2.0 |
Immunoglobulin M | 2 | 6.0 |
Rabbits/immunology | 3 | 3.0 |
Acute Disease | 2 | 0.0 |
